関連する実験動画
Updated: Aug 7, 2026
08:28
Experimental Metastasis Assay
Published on: August 24, 2010
マトリックスメタルプロテインアース阻害剤と癌:試行錯誤と試練
Lisa M Coussens1, Barbara Fingleton, Lynn M Matrisian
1Department of Pathology and Cancer Research Institute, University of California, 2340 Sutter Street, San Francisco, CA 94143, USA.
Science (New York, N.Y.)
|March 30, 2002
まとめ
マトリックスメタルプロテインアース阻害剤 (MPI) は,MMPによるがん治療において有望であることが示されています.
科学分野:
- 腫瘍学 腫瘍学
- バイオケミストリー バイオケミストリー
背景:
- マトリックス金属タンパク質酵素 (MMPs) は悪性組織で上調され,細胞外マトリクスを劣化させます.
- MMPは,がん治療の有望な治療標的と考えられてきました.
- 合成メタルプロテインアース阻害剤 (MPI) は,説得力のある臨床前データに基づいて開発されました.
研究 の 目的:
- MPIの臨床試験につながる研究をレビューする.
- MPI試験の設計と結果を,新しいMMP情報に照らして議論する.
- 将来のMPI研究とがん薬の開発のための教訓を引き出すために.
主な方法:
- MPIの臨床前試験とヒト臨床試験のレビュー.
- MMPの細胞源,基板,および腫瘍進行中の作用に関する新しい情報の分析.
主要な成果:
- 臨床前研究では,MMP抑制の説得力のある有効性が示されました.
- MPIを用いたヒトでの臨床試験は,期待を裏切る結果を出してきた.
- 新しいデータは,異なる腫瘍進行段階におけるMMPの役割の複雑さを明らかにしています.
結論:
- MPIの臨床的失敗は,前臨床的約束と治療的現実の間のギャップを強調しています.
- MMPの多様な役割を理解することは,効果的ながん治療に不可欠です.
- MPIの経験から得た教訓は,将来のがん薬の開発を導くことができます.
関連する概念動画
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...